US Stock MarketDetailed Quotes

AGRX Agile Therapeutics

  • 0.394
  • +0.014+3.68%
15min DelayClose Apr 22 15:58 ET
2.70MMarket Cap-58P/E (TTM)

About Agile Therapeutics Company

Agile Therapeutics, Inc. is a healthcare company, which engages in the development and commercialization of transdermal patches. Its lead product candidate, Twirla, also known as AG200-15, is an investigational low-dose, non-daily prescription contraceptive. The company was founded by Chien Te Yen on December 22, 1997 and is headquartered in Princeton, NJ.

Company Profile

Company NameAgile Therapeutics
Listing DateMay 23, 2014
Issue Price6.00
CEOMr. Alfred F. Altomari
MarketPink Market
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address500 College Road East,Suite 310
ProvinceNew Jersey
CountryUnited States of America
Zip Code08540-1715

Company Executives

  • Name
  • Position
  • Salary
  • Alfred F. Altomari
  • Chairman of the Board and Chief Executive Officer
  • 2.41M
  • Geoffrey P. Gilmore,J.D.
  • Senior Vice President Chief Administrative Officer
  • 1.16M
  • Amy Welsh
  • Senior Vice President and Chief Commercial Officer
  • --
  • Scott M. Coiante
  • Senior Vice President, Chief Financial Officer and Treasurer
  • --
  • Robert G. Conway
  • Senior Vice President and Chief Corporate Planning and Supply Chain Officer
  • --
  • Paul Korner
  • Senior Vice President and Chief Medical Officer
  • 975.09K
  • Seth H.Z. Fischer
  • Lead Independent Director
  • 170.00K
  • Josephine Torrente
  • Independent Director
  • 150.00K
  • Dr. John W. Hubbard
  • Independent Director
  • 140.00K
  • Sharon Surrey-Barbari
  • Independent Director
  • 145.00K
  • Dr. Sandra Carson, M.D.
  • Independent Director
  • 130.00K


Analyst Rating

No Data

Price Target

No Data

Heat List
Latest Price